The global alcoholic liver diseases (ALD) treatment market is witnessing a pivotal shift toward advanced therapeutics and proactive public health intervention, projected to grow from US$ 2.29 billion in 2024 to US$ 4.84 billion by 2034. According to the latest industry outlook by Fact.MR, this 7.8% CAGR is being fueled by a rising global patient base and...